News

SolarEdge Strengthens Leadership with New Board Members

SolarEdge Strengthens Leadership with New Board Members

SolarEdge Strengthens Leadership with New Board Members

SolarEdge Technologies, Inc. (NASDAQ: SEDG), a renowned leader in smart energy technology, has announced the recent appointments of Yoram Tietz and Gilad Almogy to its Board of Directors. This significant move is expected to bolster the Board's expertise as the company navigates the evolving energy landscape.

Meet Yoram Tietz

Yoram Tietz brings a wealth of experience to the board. Currently a Senior Advisor to General Atlantic, a prominent global growth equity investment firm, he has spent an impressive 27 years at Ernst & Young (EY). Tietz's leadership as Managing Partner of EY Israel for over 15 years is noteworthy, and he also led the High-Tech Cluster at EY Israel, where he played a crucial advisory role to many prominent tech entrepreneurs.

Community Engagement

In addition to his corporate commitments, Tietz is the Chairman of the Friends of Sheba Medical Center, where he supports initiatives focused on innovation in healthcare. His philanthropic endeavors extend to being the Co-Founder and Chairman of Birthright Excel, an organization that empowers young Jewish adults globally.

Introducing Gilad Almogy

Joining Tietz is Gilad Almogy, the Founder and CEO of Ultima Genomics, recognized for pioneering a $100 human genome sequencing solution. Since launching Ultima Genomics in 2016, he has dedicated his efforts to lowering the costs of genomic sequencing, enabling wider access to essential healthcare resources.

A Impressive Track Record

Before his current role, Almogy was at the helm of Cogenra Solar, known for its groundbreaking shingled solar modules, contributing to multiple gigawatts deployed around the globe. His journey also includes significant achievements at Applied Materials (NASDAQ: AMAT), where he oversaw a substantial revenue-generating division.

Strategic Insights for SolarEdge

According to Avery More, Chairman of the Board, the addition of both Tietz and Almogy enhances SolarEdge's leadership capabilities as they aim to meet financial and strategic challenges. Their combined expertise in finance and technology is anticipated to enrich the company's discussions and decisions moving forward.

About SolarEdge

SolarEdge is a forefront player in smart energy solutions, leveraging exceptional engineering prowess to provide innovative products that drive sustainable energy use. Their intelligent inverter technology revolutionized energy management in photovoltaic (PV) systems. By optimizing power generation and reducing energy costs, SolarEdge is committed to advancing clean energy solutions across various market sectors, including storage, electric vehicle charging, and grid services.

Frequently Asked Questions

1. Who are the new appointments to SolarEdge's Board of Directors?

Yoram Tietz and Gilad Almogy have been appointed to the Board, bringing extensive experience in finance and technology.

2. What roles will Yoram Tietz and Gilad Almogy serve in?

Tietz will chair the Audit Committee, while Almogy will join the Technology Committee.

3. What contributions has Yoram Tietz made in his career?

Tietz has significant experience with Ernst & Young and is involved in various philanthropic initiatives, especially in healthcare.

4. What is the vision of SolarEdge?

SolarEdge aims to create a world powered by clean, sustainable energy through innovative technology and solutions.

5. How does SolarEdge contribute to advancements in energy?

By developing cutting-edge technologies in PV systems, storage, and EV charging, SolarEdge is at the forefront of the energy transition.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 26

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 35

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 24

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 35

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 34

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 37

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading

Top 5 Most Recently Viewed Articles

Man Group PLC Highlights Its Strategic Disclosures on Tritax REIT

Updated Category News Views 148

Strategic Position Disclosure by Man Group PLC Man Group PLC is actively sharing its significant interests in the securities market, particularly focusing on its involvement with Tritax Big Box REIT plc. As a key player in the investment landscape, this disclosure marks an important step for the company regarding its strategic holdings. Key Information Pertaining to the...

Continue Reading
TalentLMS and Epignosis Lead the Way in GDPR Compliance

Updated Category News Views 720

TalentLMS and Epignosis Set the Standard for GDPR Compliance TalentLMS, along with its parent company Epignosis, has continuously led the way in providing a fully compliant Learning Management System (LMS) with regards to the General Data Protection Regulation (GDPR). Recent developments affirm that TalentLMS remains the only LMS globally to uphold its commitment to this...

Continue Reading
Zillow and Esusu Forge New Path to Boost Renters' Credit Scores

Updated Category News Views 283

Building Credit for Renters with Zillow and Esusu The recent collaboration between Zillow and Esusu marks a significant step towards empowering renters across the country to build their credit. This partnership allows any renter to report their on-time rent payments, significantly enhancing their credit profiles, for just $20 a year. How the Partnership Works Starting...

Continue Reading
iCrowdNewswire Leverages DeepL for Enhanced Global Communication

Updated Category News Views 121

iCrowdNewswire Enhances Multilingual Capabilities iCrowdNewswire, a prominent international press release distribution company, has embarked on a transformative journey to improve its multilingual services through the introduction of the DeepL API. The integration of DeepL's cutting-edge language AI technology has significantly boosted iCrowdNewswire’s ability to...

Continue Reading
Celebrating Excellence: Top Surgeons Recognized in Endocrine Care

Updated Category News Views 82

Exceptional Recognition for Leading Surgeons in Endocrine Surgery Dr. Jim Norman and Dr. Gary Clayman Acknowledged as Premier Specialists The Hospital for Endocrine Surgery is proud to announce that two of its distinguished surgeons, Dr. Jim Norman and Dr. Gary Clayman, have been honored in the prestigious Castle Connolly Top Doctors list for 2025. This remarkable...

Continue Reading